Sunrise's Hyperion Laser Gains FDA Approval For Hyperopia
This article was originally published in The Gray Sheet
Executive Summary
Sunrise Technologies' procedure fee for its Hyperion laser thermal keratoplasty system will be based on the number of procedures a doctor is willing to commit to, according to the company. The device was approved June 29 for treatment of hyperopia (farsightedness).